您的位置: 首页 > 农业专利 > 详情页

Double acting pharmaceutical compositions based on superstructures of angiotensin receptor antagonists / blockers (arb) and neutral endopeptidase (nep) inhibitors
专利权人:
Novartis AG
发明人:
Al-Fayoumi, Suliman,Hu, Jiahui,Kumaraperumal, Natrajan,ROYCE, Alan Edward,RUEGGER, Colleen,Zannou, Erika Aina
申请号:
DK10173506
公开号:
DK2295035T3
申请日:
2008.11.04
申请国别(地区):
DK
年份:
2016
代理人:
摘要:
Solid oral dosage forms, especially tablets, of a pharmaceutical composition comprising a supramolecular complex can be formed from a direct compression process or a compaction process such as roller compaction. Such solid oral dosage forms feature an immediate release profile that allows for fast release of the therapeutic agent. A particularly useful supramolecular complex is trisodium [3-((1S,3R)-1-biphenyl-4-ylmethyl-3-ethoxycarbonyl-1-butylcarbamoyl) propionate-(S)-3'-methyl-2'-(pentanoyl{2"-(tetrazol-5-ylate)biphenyl-4'-ylmethyl}amino)butyrate]hemipentahydrate.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/
相关发明人
相关专利

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充